Table 1.
Demographical information of the studied population.
| Placebo group | Curcumin group | Value of p | |
|---|---|---|---|
| Gender | |||
| Male | 6 (40.0%) | 23 (65.7%) | |
| Female | 9 (60.0%) | 12 (34.3%) | |
| Age | 32.42 ± 9.6 | 36.28 ± 10.73 | 0.17* |
| Age of onset of disease | 25.57 ± 7.48 | 25.92 ± 7.01 | 0.85* |
| Job | |||
| Homemaker | 7 (26.9%) | 12 (42.9%) | 0.69** |
| Unemployed | 16 (61.5%) | 11 (39.3%) | |
| Retired | 1 (3.8%) | 1 (3.6%) | |
| Self-employed | 1 (3.8%) | 2 (7.1%) | |
| Full-time student | 1 (3.8%) | 2 (7.1%) | |
| Education | |||
| Primary school | 11 (42.3%) | 16 (57.1%) | 0.56** |
| High school diploma | 12 (46.2%) | 10 (35.7%) | |
| Higher than high school diploma | 3 (11.5%) | 2 (7.1%) | |
| Number of previous hospitalizations | |||
| 1 or less | 10 (38.5%) | 5 (17.9%) | 0.17*** |
| 2–3 times | 13 (50.0%) | 16 (57.1%) | |
| More than 3 times | 3 (11.5%) | 7 (25.0%) | |
| History of inflammatory disease | |||
| Yes | 2 (7.7%) | 3 (10.7%) | >0.99** |
| No | 24 (92.3%) | 25 (89.3%) | |
| Family history of depression | |||
| Yes | 15 (57.7%) | 10 (35.7%) | 0.1*** |
| No | 11 (42.3%) | 18 (64.3%) | |
| History of depression | |||
| Yes | 10 (38.5%) | 6 (21.4%) | 0.17*** |
| No | 16 (61.5%) | 22 (78.6%) | |
| History of physical illness | |||
| Yes | 8 (30.8%) | 10 (35.7%) | 0.77** |
| No | 18 (69.2%) | 18 (64.3%) | |
| Medicine | 0.06** | ||
| Risperidone | 9 (34.6%) | 10 (35.7%) | |
| Alprazoplam | 2 (7.7%) | 8 (28.6%) | |
| Olanzapin | 8 (30.8%) | 4 (14.3%) | |
| Lithium | 2 (7.7%) | 5 (17.9%) | |
| Tranqopine | 5 (19.2%) | 1 (3–6%) | |
*Independent t-test. **Fisher’s exact test. ***Chi-squared test.